Finance

Lists
300119:SHE
Tianjin Ringpu Bio-Technology Co Ltd
CNÂ¥16.90
-0.06%
(-0.010) 1D
Nov 4, 3:04:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300119...
Open
CNÂ¥16.88
High
CNÂ¥17.10
Low
CNÂ¥16.71
Mkt. cap
7.86B
Avg. vol.
3.66M
Volume
4.47M
Dividend
2.37%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 13, 2026
P/E ratio
22.58
52-wk high
CNÂ¥21.51
52-wk low
CNÂ¥13.91
EPS
CNÂ¥0.75
Shares outstanding
464.75M
No. of employees
3K
Open
CNÂ¥16.88
High
CNÂ¥17.10
Low
CNÂ¥16.71
Mkt. cap
7.86B
Avg. vol.
3.66M
Volume
4.47M
Dividend
2.37%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 13, 2026
P/E ratio
22.58
52-wk high
CNÂ¥21.51
52-wk low
CNÂ¥13.91
EPS
CNÂ¥0.75
Shares outstanding
464.75M
No. of employees
3K
News stories
From web sources and news partners
About Tianjin Ringpu Bio-Technology Co Ltd
CEO-
Employees2.8K
Founded1998
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteringpu.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
854.13M
826.13M
894.33M
950.05M
Cost of goods sold
527.91M
497.91M
540.18M
570.79M
Cost of revenue
527.91M
497.91M
540.18M
570.79M
Research and development expenses
94.71M
45.33M
60.85M
66.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
184.65M
144.66M
163.41M
183.86M
Operating expense
304.33M
204.46M
240.88M
216.20M
Total operating expenses
832.24M
702.37M
781.06M
787.00M
Operating income
21.89M
123.75M
113.27M
163.05M
Other non operating income
-4.59M
-1.05M
-1.46M
-50.25M
EBT including unusual items
30.18M
128.46M
112.52M
133.68M
EBT excluding unusual items
-15.83M
124.19M
100.42M
130.26M
Income tax expense
-13.50M
11.05M
8.02M
11.51M
Effective tax rate
-44.72%
8.61%
7.12%
8.61%
Other operating expenses
18.54M
4.09M
10.86M
-18.47M
Net income
38.21M
107.78M
96.33M
94.74M
Net profit margin
4.47%
13.05%
10.77%
9.97%
Earnings per share
-
-
-
-
Interest and investment income
-
9.65M
-
16.06M
Interest expense
-32.99M
-8.16M
-9.75M
-244.88K
Net interest expenses
-32.99M
1.49M
-9.75M
15.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
74.51M
176.38M
164.94M
215.67M
Gain or loss from assets sale
-3.82M
-
-2.82K
2.82K
Upcoming events
AI content may include mistakes. Learn more
Google apps